Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pariente
Edouard Louis

Showing results (291-300 of 364) with videos related to

Pageof 37
Sort By:
Alimentary Pharmacology & Therapeutics|April 16, 2020
Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort studyAurélien Amiot, Jérôme Filippi, Vered Abitbol, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 3, 2016
Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-upElisabeth De Greef, Ilse Hoffman, Francoise Smets, et al.
Journal of Crohn'S & Colitis|January 13, 2025
Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studiesRemo Panaccione, Edouard Louis, Jean-Frederic Colombel, et al.
Gastroenterology|August 8, 2022
Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled TrialMarie Truyens, Triana Lobatón, Marc Ferrante, et al.
The American Journal of Gastroenterology|December 6, 2012
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion processLaurent Peyrin-Biroulet, Vincent Billioud, Geert D'Haens, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2017
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained RemissionCatherine Reenaers, Jean-Yves Mary, Maria Nachury, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2020
Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort studyPauline Wils, Philippe Seksik, Carmen Stefanescu, et al.
The American Journal of Gastroenterology|December 14, 2016
Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND GroupMathurin Fumery, Philippe Seksik, Claire Auzolle, et al.
The European Respiratory Journal|February 13, 2025
Association of fibrotic-related extracellular vesicle microRNAs with lung involvement in systemic sclerosisJulien Guiot, Béatrice André, Judith Potjewijd, et al.
Nature Reviews. Gastroenterology & Hepatology|August 28, 2021
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel diseasePablo A Olivera, Stephane Zuily, Paulo G Kotze, et al.
Pageof 37

Showing results (291-300 of 364) with videos related to

Sort By:
Pageof 37
Alimentary Pharmacology & Therapeutics|April 16, 2020
Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort studyAurélien Amiot, Jérôme Filippi, Vered Abitbol, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 3, 2016
Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-upElisabeth De Greef, Ilse Hoffman, Francoise Smets, et al.
Journal of Crohn'S & Colitis|January 13, 2025
Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studiesRemo Panaccione, Edouard Louis, Jean-Frederic Colombel, et al.
Gastroenterology|August 8, 2022
Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled TrialMarie Truyens, Triana Lobatón, Marc Ferrante, et al.
The American Journal of Gastroenterology|December 6, 2012
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion processLaurent Peyrin-Biroulet, Vincent Billioud, Geert D'Haens, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2017
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained RemissionCatherine Reenaers, Jean-Yves Mary, Maria Nachury, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2020
Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort studyPauline Wils, Philippe Seksik, Carmen Stefanescu, et al.
The American Journal of Gastroenterology|December 14, 2016
Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND GroupMathurin Fumery, Philippe Seksik, Claire Auzolle, et al.
The European Respiratory Journal|February 13, 2025
Association of fibrotic-related extracellular vesicle microRNAs with lung involvement in systemic sclerosisJulien Guiot, Béatrice André, Judith Potjewijd, et al.
Nature Reviews. Gastroenterology & Hepatology|August 28, 2021
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel diseasePablo A Olivera, Stephane Zuily, Paulo G Kotze, et al.
Pageof 37